Karen Olsen, PhD, is a science writer at the AACR, where she facilitates the communication of the latest cancer research to the general public and to the trade press. Before joining the AACR, Olsen completed her postdoctoral training at the Wistar Institute in Philadelphia, where she investigated the role that epigenetic regulators play in cancers and neuronal disorders. She received her doctorate in chemistry from Purdue University, where she focused on integral membrane proteins associated with disease. Olsen lives in Center City Philadelphia.
Early detection of cancer is arguably a holy grail in the field of cancer research. Catching the disease at an early stage could ultimately prevent thousands of deaths from late-diagnosed disease, which is more challenging to treat. Early detection tests exist for a handful of individual cancers, but no approved method can simultaneously screen for multiple types of cancer.Read More